Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
04/2004
04/20/2004USRE38506 Potent inducers of terminal differentiation and methods of use thereof
04/20/2004US6723853 Anticancer agents
04/20/2004US6723852 Method for obtaining derivatives of [[(pyridil substituted)methyl]thio]benzomidazol
04/20/2004US6723847 3-oxo-n-(5-phenyl-2-pyrimidinyl)spiro(4-azaisobenzofuran-1 (3h),1'-cyclohexane)-4'-carboxamide; neuropeptide y receptor antagonists
04/20/2004US6723835 Printing dye; color filter; yellow; carboxy groups ortho to the azo linkage provide lightfastness versus related ortho-sulpho analogues, with no loss in brightness
04/20/2004US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
04/20/2004US6723752 (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
04/20/2004US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis
04/20/2004US6723730 Capsaicin receptor ligands
04/20/2004US6723716 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof
04/20/2004US6723711 Vascular cell adhesion molecules and fibronectins; asthma, multiple sclerosis, arthritis, inflammatory bowel disease, contact hypersensitivity, cardiac allograft rejection and diabetes treatment
04/20/2004CA2215585C Practical synthesis of urea derivatives
04/15/2004WO2004031427A2 Method for producing a moulded body from sintered steel
04/15/2004WO2004031175A2 N-substituted-2-oxodihydropyridine derivatives as npy antagonists
04/15/2004WO2004031152A1 6-alkoxy-2,3-diaminopyridine couplers and use of said couplers for the dyeing of keratinous fibres
04/15/2004WO2004031151A1 Compounds capable of activating cholinergic receptors
04/15/2004WO2004031145A2 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
04/15/2004WO2004031139A1 Cyclohexyl sulphones as gamma-secretase inhibitors
04/15/2004WO2004031137A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
04/15/2004WO2004030643A1 Novel 6-alkoxy-2,3-diaminopyridine couplers in which the position 2 amino radical is a disubstituted amino radical and use of said couplers for the dyeing of keratinous fibres
04/15/2004WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same
04/15/2004WO2004014859A3 Process for preparing quinolin antibiotic intermediates
04/15/2004WO2004005321A3 Methods of inhibiting 4-hydroxyphenylpyruvate dioxygenase in a living system
04/15/2004WO2003106381A3 Human adam-10 inhibitors
04/15/2004WO2003103567A3 Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors
04/15/2004WO2003083063A3 Common ligand mimics: naphtoates
04/15/2004US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups
04/15/2004US20040073041 Method for producing monocarbonyl compounds or biscarbonyl compounds or hydroxyl compounds
04/15/2004US20040073040 Using titanium oxide composite catalyst on supports
04/15/2004US20040073039 Blocking neurotransmitter
04/15/2004US20040073033 Process for the preparation of phenylalanine enamide derivatives
04/15/2004US20040073032 Preparation of substituted aromatic compounds
04/15/2004US20040073026 Cyclic protein tyrosine kinase inhibitors
04/15/2004US20040072907 Antipicornaviral compounds, compositions containing them, and methods for their use
04/15/2004US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
04/15/2004US20040072880 Cycloalkyl inhibitors of potassium channel function
04/15/2004US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage
04/15/2004US20040072874 N-substituted-2-oxodihydropyridine derivatives
04/15/2004US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders
04/15/2004US20040072843 Novel sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
04/15/2004US20040072823 Central nervous system disorders; analgesics; antiinflammatory agents
04/15/2004US20040072821 N-substituted glycine derivatives
04/15/2004US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
04/15/2004US20040072770 Methods for specifically inhibiting histone deacetylase-7 and 8
04/15/2004DE10246626A1 Selective halogenation of alkyl aromatic compounds, useful as intermediates for the production of plant protection agents, comprises insertion of halogenating agents in a micro-reactor under photochemical induction
04/15/2004CA2726754A1 N-substituted-2-oxodihydropyridine derivatives
04/15/2004CA2500969A1 Cyclohexyl sulphones as gamma-secretase inhibitors
04/15/2004CA2494861A1 6-alkoxy-2,3-diaminopyridine couplers and use of said couplers for the dyeing of keratinous fibres
04/15/2004CA2494856A1 Novel 6-alkoxy-2,3-diaminopyridine couplers in which the position 2 amino radical is a disubstituted amino radical and use of said couplers for the dyeing of keratinous fibres
04/14/2004EP1408027A1 DIAMINE DERIVATIVE,PROCESS FOR PRODUCING THE SAME, AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT
04/14/2004EP1406877A1 Heterocyclic amines for the treatment of conditions associated with gsk-3
04/14/2004EP1406875A1 N-heterocyclic inhibitors of tnf-alpha expression
04/14/2004EP1406870A1 Taxol enhancer compounds
04/14/2004EP1406869A1 Taxol enhancer compounds
04/14/2004EP1406868A1 Synthesis of taxol enhancers
04/14/2004EP1406861A1 Substituted aromatic ethers as inhibitors of glycine transport
04/14/2004EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
04/14/2004EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors
04/14/2004EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes
04/14/2004EP1406620A1 Vinyl phenyl derivatives as glk activators
04/14/2004EP1406618A2 Use of nk-1 receptor antagonists with pyridinic structure for the treatment of brain, spinal or nerve injury
04/14/2004EP1406617A1 Diaminediols for the treatment of alzheimer's disease
04/14/2004EP1406613A1 Organic nitrate-based compounds for the treatment of vasculopathies
04/14/2004EP1406605A1 Carbamates of 2-heterocyclic-1,2-ethanediols
04/14/2004EP1161416B1 Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7 - receptor antagonists
04/14/2004EP1073641B1 New substituted amides, their production and their use
04/14/2004EP1064265B1 Synthesis of 3-amino-2-chloro-4-methylpyridine from malononitrile and acetone
04/14/2004EP1054907B1 Method for producing aqueous polymer dispersions containing colorants
04/14/2004EP1054867B1 Antivirals
04/14/2004EP1028110B1 Novel dihydronaphthalene compounds and process for producing the same
04/14/2004EP0724561B1 Calcium receptor-active arylalkyl amines
04/14/2004CN1489619A Azodyes, preparing method thereof and use in production of cloured plastics or polymer colour particles, and in the dyeing or printing of hydrophobic fiber materials
04/14/2004CN1489576A Cannabinod receptor ligands
04/14/2004CN1489458A Inhibitors against the production and releaseof inflammator cytokines
04/14/2004CN1488620A 2-phenyl-camphol propionate derivativ and synthesizing method thereof
04/14/2004CN1145613C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing same
04/14/2004CN1145609C Piperazine compounds and medical use thereof
04/13/2004US6720426 From 4-vinylpyridine and thiourea in an aqueous medium containing an acid to form an isothiuronium salt; making alkaline to convert the salt into the thiol
04/13/2004US6720424 Vegf (vascular endothelial growth factor) receptor antagonists and angiogenesis inhibitors suppress vascular hyperpermeability; phenylalkylcarbonyl substituent on the amino
04/13/2004US6720341 Preventives/remedies for kidney diseases
04/13/2004US6720338 Bcl-x1 inhibiting compositions and methods of promoting apoptosis in a mammal
04/13/2004US6720335 Sulfonamide inhibitors of aspartyl protease
04/13/2004US6720328 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion)
04/13/2004US6720321 1,4-disubstituted benzo-fused cycloalkyl urea compounds
04/13/2004US6720317 Inhibitors of factor Xa
04/13/2004US6720315 Dihydrostilbene alkanoic acid derivatives
04/08/2004WO2004029212A2 In vivo gene silencing by chemically modified and stable sirna
04/08/2004WO2004029027A1 Pyridine derivatives as cb2 receptor modulators
04/08/2004WO2004029026A1 Pyridine derivatives as cb2 receptor modulators
04/08/2004WO2004029017A1 Novel quaternary ammonium compounds
04/08/2004WO2003097622A3 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
04/08/2004WO2003084503A3 P38 kinase inhibitors for treating mucus hypersecretion_
04/08/2004WO2003070690A3 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
04/08/2004WO2003051276B1 Therapeutic heterocycles
04/08/2004WO2002032856A9 Insecticidal 1,8-naphthalenedicarboxamides
04/08/2004US20040068118 Conjugated aromatic compounds with a pyridine substituent
04/08/2004US20040068115 Charge transport compositions and electronic devices made with such compositions
04/08/2004US20040068113 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
04/08/2004US20040068016 C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
04/08/2004US20040068012 Anticancer agents; protease enzyme inhibitor